130
Participants
Start Date
June 30, 2010
Primary Completion Date
January 31, 2015
Study Completion Date
March 31, 2015
Eltrombopag olamine
thrombopoietin receptor agonist
Placebo
Placebo tablets with no active pharmaceutical ingredient
GSK Investigational Site, Dublin
GSK Investigational Site, Dublin
GSK Investigational Site, Tallaght, Dublin
GSK Investigational Site, Budapest
GSK Investigational Site, Leuven
GSK Investigational Site, Namur
GSK Investigational Site, Charleroi
GSK Investigational Site, Libramont
GSK Investigational Site, Kaposvár
GSK Investigational Site, Zalaegerszeg
GSK Investigational Site, Győr
GSK Investigational Site, Berlin
GSK Investigational Site, Albany
GSK Investigational Site, Berlin
GSK Investigational Site, Wynnewood
GSK Investigational Site, Philadelphia
GSK Investigational Site, Milan
GSK Investigational Site, Bethesda
GSK Investigational Site, Rockville
GSK Investigational Site, Norfolk
GSK Investigational Site, Greensboro
GSK Investigational Site, Greenville
GSK Investigational Site, Rome
GSK Investigational Site, Hanover
GSK Investigational Site, Savannah
GSK Investigational Site, Jacksonville
GSK Investigational Site, Aviano (PN)
GSK Investigational Site, Tampere
GSK Investigational Site, Haifa
GSK Investigational Site, New Port Richey
GSK Investigational Site, Goslar
GSK Investigational Site, Modena
GSK Investigational Site, Kfar Saba
GSK Investigational Site, Essen
GSK Investigational Site, Pisa
GSK Investigational Site, Tel Aviv
GSK Investigational Site, Columbia
GSK Investigational Site, Wichita
GSK Investigational Site, Zrifin
GSK Investigational Site, Heraklion, Crete
GSK Investigational Site, Hot Springs
GSK Investigational Site, Dallas
GSK Investigational Site, Tyler
GSK Investigational Site, Arlington
GSK Investigational Site, Bedford
GSK Investigational Site, San Antonio
GSK Investigational Site, Ashkelon
GSK Investigational Site, Austin
GSK Investigational Site, Freiburg im Breisgau
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Augsburg
GSK Investigational Site, Sedona
GSK Investigational Site, Las Vegas
GSK Investigational Site, Jerusalem
GSK Investigational Site, Rancho Cucamonga
GSK Investigational Site, Bend
GSK Investigational Site, Edmonds
GSK Investigational Site, Tacoma
GSK Investigational Site, Vancouver
GSK Investigational Site, Yakima
GSK Investigational Site, Pune
GSK Investigational Site, Pune
GSK Investigational Site, Madurai
GSK Investigational Site, Norwich
GSK Investigational Site, Cherry Hill
GSK Investigational Site, Providence
GSK Investigational Site, Providence
GSK Investigational Site, Edmonton
GSK Investigational Site, Toronto
GSK Investigational Site, Olomouc
GSK Investigational Site, Prague
GSK Investigational Site, Prague
GSK Investigational Site, Helsinki
GSK Investigational Site, Dresden
GSK Investigational Site, Dresden
GSK Investigational Site, Athens
GSK Investigational Site, Athens
GSK Investigational Site, Thessaloniki
GSK Investigational Site, Törökbálint
GSK Investigational Site, Sassari
GSK Investigational Site, Bialystok
GSK Investigational Site, Konin
GSK Investigational Site, Olsztyn
GSK Investigational Site, Poznan
GSK Investigational Site, Poznan
Lead Sponsor
GlaxoSmithKline
INDUSTRY